Protein-fatty acid conjugate for self-assembled nanoparticles in drug delivery

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Novel biocompatible protein-oleic acid conjugate was prepared to form self-assembled nanoparticles (NP) when exposed to an aqueous medium. The conjugation of protein-fatty acid was confirmed using FTIR and NMR. The physicochemical properties of NP were characterized by the experimental conditions such as pH, temperature and the amount of protein/fatty acid. The self-assembled NP had a uniformly spherical shape with particle size (150-200 nm) and showed good physical stability. This NP had no any potential cellular toxicity. Paclitaxel was chosen as model drug for anti-cancer effect using self-assembled NP. Drug release was controlled over an extended period of time. Furthermore, surface-modified NP using folic acid showed a higher cancer-cell killing effect as compared with Taxol®. The in vivo pharmacokinetic parameters and biodistribution of the NP containing paclitaxel also indicated longer blood circulation. © 2013 IFMBE.

Cite

CITATION STYLE

APA

Lee, B. J., & Tran, P. H. L. (2013). Protein-fatty acid conjugate for self-assembled nanoparticles in drug delivery. In IFMBE Proceedings (Vol. 40 IFMBE, pp. 301–303). https://doi.org/10.1007/978-3-642-32183-2_75

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free